Skip to main content

General Nephrology

General Nephrology

Stage IV Chronic Kidney Disease

Hanna Abboud, M.D., and William L. Henrich, M.D
N Engl J Med. 2010 Jan 7;362(1):56-65

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group
J Am Soc Nephrol. 2009 May;20(5):1103-12

Intensity of renal support in critically ill patients with acute kidney injury

VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P
N Engl J Med. 2008 Jul 3;359(1):7-20

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial

Grootscholten C, Ligtenberg G, Hagen EC, van den Wall Bake AW, de Glas-Vos JW, Bijl M, Assmann KJ, Bruijn JA, Weening JJ, van Houwelingen HC, Derksen RH, Berden JH; Dutch Working Party on Systemic Lupus Erythematosus
Kidney Int. 2006 Aug;70(4):732-42. Epub 2006 Jul 5

Comparison of two fluid-management strategies in acute lung injury

National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network1, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL
N Engl J Med. 2006 Jun 15;354(24):2564-75. Epub 2006 May 21

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB
N Engl J Med. 2005 Nov 24;353(21):2219-28
<<  1 2 [34  >>  
ukidneyisup